Dantron Syrup

About Dantron 4 mg/5 ml Syrup

Dantron Syrup is an anti-emetic medicine made by One Pharma Ltd. that contains ondansetron 4 mg/5 ml. It is used to help prevent nausea and vomiting in certain treatment situations. A doctor decides whether it suits a particular person.

There are 74 brands of Ondansetron listed in Bangladesh. 36 of them have a lower unit price than Dantron. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.

What is Dantron 4 mg/5 ml Syrup?

Dantron Syrup is a liquid anti-emetic medicine containing ondansetron at 4 mg/5 ml, supplied in a 50 ml bottle by One Pharma Ltd. Ondansetron belongs to a group of medicines that block a specific serotonin receptor in the body, which is involved in the vomiting reflex. It is prescribed to help prevent nausea and vomiting linked to some cancer chemotherapy, radiotherapy and surgery. Because it is a syrup, it may be considered for people who find tablets difficult. Whether it is appropriate, and how it is used, is decided by a doctor.

Uses of Dantron

Dantron Syrup is used to help prevent nausea and vomiting associated with initial and repeat courses of cancer chemotherapy that can cause vomiting. It is also used to prevent and treat nausea and vomiting after an operation, and to prevent nausea and vomiting caused by radiotherapy. It is an anti-emetic medicine, not a treatment for the cancer itself. A doctor decides whether it is suitable for a particular situation.

How to use Dantron

Dantron Syrup is given by mouth as a liquid. The amount to take and how often, and for how long, are decided by the doctor for each person; no fixed amount applies to everyone. Follow the doctor's instructions and the directions on the label, and ask a pharmacist if anything is unclear. Do not change the amount on your own. Store it below 30°C in a dry place, away from light and moisture.

Side effects of Dantron

Headache, constipation and diarrhoea are among the more frequently reported side effects, and most are mild or moderate. A rash has been reported in some patients receiving ondansetron for chemotherapy-related nausea and vomiting. A feeling of flushing or warmth and hiccups have also been reported, along with liver enzyme abnormalities. Rare reports include allergic-type reactions, wheezing, fast heartbeat, chest pain, low potassium and shortness of breath. Tell the doctor about any side effect that worries you.

Safety and precautions

Do not use Dantron Syrup if there is a known hypersensitivity to ondansetron or any ingredient, or with apomorphine. Tell the doctor about allergies, especially to other similar anti-emetic medicines, and about liver problems or recent abdominal surgery. It does not stimulate stomach or bowel movement and should not replace nasogastric suction. It may mask a developing ileus or stomach distension after surgery. Pregnancy and breastfeeding should be discussed with the doctor, as controlled studies in pregnant women are lacking. Ask the doctor first if any of these apply.

Frequently asked questions

How much does Dantron Syrup cost?

The listed price is ৳ 45.00. Ask the pharmacist about availability and any other charges.

How should Dantron Syrup be taken?

It is a liquid taken by mouth. The doctor decides the amount, how often it is given and how long it is continued for each person. Follow the doctor's directions and the label, and ask a pharmacist if anything is unclear.

What is Dantron Syrup used for and what kind of medicine is it?

It is an anti-emetic medicine containing ondansetron. It is used to help prevent nausea and vomiting linked to some cancer chemotherapy, radiotherapy and surgery. It does not treat the underlying condition itself.

Who should avoid Dantron Syrup or ask the doctor first?

Do not use it with apomorphine or if you are allergic to ondansetron or any ingredient. Ask the doctor first if you are pregnant or breastfeeding, have liver problems, had recent abdominal surgery, or have had reactions to similar medicines.

Syrup
Generic name
Ondansetron
Strength
4 mg/5 ml
Dosage form
Syrup
Manufactured by
One Pharma Ltd.
Price in Bangladesh

৳ 44.1 ৳ 45.00 2% off unit price

Price updated: 18 Nov 2026

Also available as

8 mg (Tablet)

Indications

Ondansetron is a serotonin subtype 3 (5-HT3) receptor antagonist indicated:
  • Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
  • Prevention and treatment of post-operative nausea and vomiting.
  • Prevention of radiotherapy-induced nausea and vomiting.

Pharmacology

Ondansetron is a potent, highly selective 5HT3 receptor-antagonist. Its precise mode of action in the control of nausea and vomiting is not known. Chemotherapeutic agents and radiotherapy may cause release of 5HT in the small intestine initiating a vomiting reflex by activating vagal afferents via 5HT3 receptors. Ondansetron blocks the initiation of this reflex. Activation of vagal afferents may also cause a release of 5HT in the area postrema, located on the floor of the fourth ventricle, and this may also promote emesis through a central mechanism. Thus, the effect of ondansetron in the management of the nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy is probably due to antagonism of 5HT3 receptors on neurons located both in the peripheral and central nervous system. The mechanisms of action in post-operative nausea and vomiting are not known but there may be common pathways with cytotoxic induced nausea and vomiting.

Dosage & Administration

Chemotherapy-Induced Nausea and Vomiting-
Adults, Pediatric patients (6 months to 18 years):
  • 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
  • 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
  • Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Radiotherapy-Induced Nausea and Vomiting-
Adults:
  • 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
  • 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
  • Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Postoperative Nausea and Vomiting-
Adults:
  • 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
  • 4 mg orodispersible tablet: 16 mg
  • Injection: 4 mg
Pediatrics (>40 kg): Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg

Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
  • Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
  • Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Pediatric (4-11 years): 5 ml (4 mg) Ondansetron Oral Solution should be taken 30 minutes before the start of chemotherapy. The other 2 doses should be taken 4 and 8 hours after the first dose. Then 5 ml oral solution should be administered 3 times a day (every 8 hours) for 1-2 days after completion of chemotherapy.


Oral solution:

Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):
  • The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
  • For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
  • For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
  • For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
Postoperative Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):
  • 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia


Oral Soluble Film:

Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:
  • Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
Prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy:
  • Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
  • Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
  • Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
  • Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.

Interaction

Ondansetron does not itself appear to induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system of the liver. Because Ondansetron is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes, inducers or inhibitors of these enzymes may change the clearance and hence, the half-life of Ondansetron. On the basis of available data, no dosage adjustment of Ondasetron is recommended for patients on these drugs.

Contraindications

Contraindicated in patients known to have hypersensitivity to the drug or any of its components. Concomitant use of apomorphine.

Side Effects

Frequently reported adverse events were headache, constipation and diarrhea, but the majority have been mild or moderate in nature. In chemotherapy-induced nausea and vomiting, rash has occurred in approximately 1% of patients receiving Ondansetron. There also have been reports to a sensation of flushing or warmth, hiccups and liver enzyme abnormalities. Rare cases of anaphylaxis, brochospasm, tachycardia, angina (chest pain), hypokalemia, shortness of breath have also been reported, except for bronchospasm and anaphylaxis, the relationship to Ondansetron is unclear. There have been no evidence to extrapyramidal reactions, in rare case oculogyric crisis appearing alone, as well as with other dystonic reactions without definitive clinical evidence. In case of PONV, with the exception of headache, rates of these events were not significantly different in the Ondansetron and placebo groups.

Pregnancy & Lactation

Carcinogenic effects were not seen in 2-year studies in rats and mice with oral Ondansetron doses up to 10 and 30 mg/kg per day, respectively. Ondansetron was not mutagenic in standard tests for mutagenicity. Oral administration of Ondansetron up to 15 mg/kg per day did not affect fertility or general reproduction performance of male and female rats.

Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.

Precautions & Warnings

Hypersensitivity reactions have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists. Ondansetron is not a drug that stimulates gastric or intestinal peristalsis. It should not be used instead of nasogastric suction. The use of Ondansetron in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension.

Storage Conditions

Store at temperature not exceeding 30ºC in a dry place. Protect from light and moisture.

Alternative brands of Ondansetron

Other brands with the same generic name, cheapest first.

Periset Suppository

16 mg

Ondansetron

The ACME Laboratories Ltd.

৳ 0.98 ৳ 1 2% off per unit

Oncodex Tablet

4 mg

Ondansetron

Jayson Pharmaceuticals Ltd.

৳ 4.44 ৳ 4.53 2% off per unit

Seton Tablet

4 mg

Ondansetron

Delta Pharma Limited

৳ 4.9 ৳ 5.00 2% off per unit

Seton Tablet

8 mg

Ondansetron

Delta Pharma Limited

৳ 4.9 ৳ 5.00 2% off per unit

Oncodex Tablet

8 mg

Ondansetron

Jayson Pharmaceuticals Ltd.

৳ 7.9 ৳ 8.06 2% off per unit

Emiteron Tablet

8 mg

Ondansetron

Premier Pharmaceuticals Ltd.

৳ 8.82 ৳ 9.00 2% off per unit

Periset Tablet

8 mg

Ondansetron

The ACME Laboratories Ltd.

৳ 9.83 ৳ 10.03 2% off per unit

Osetron Tablet

8 mg

Ondansetron

Advanced Chemical Industries PLC

৳ 9.87 ৳ 10.07 2% off per unit

See all 74 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.